Theolytics: Funding, Investors & Team (Sep 2026)
Theolytics is a biotechnology company in the clinical stage that uses viruses to fight against diseases. Our innovative phenotypic screening Platform allows for the development of effective and targeted candidate treatments, suitable for intravenous delivery and tailored to specific patient groups. Along with progressing our own programs for treating both solid and liquid tumors, we are forming partnerships to further expand and speed up the development of our pipeline.
Theolytics has raised $67.6M across 4 funding rounds on record, the most recent an undisclosed round of $9.3M announced in Mar 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Theolytics Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Theolytics Funding Rounds
Theolytics raised $6.8M in a Series A announced in Jan 2021.
2.6 years later, a Series A of $27.9M was announced in Aug 2023.
8 months later, an undisclosed round of $23.6M was announced in Apr 2024.
1.9 years later, an undisclosed round of $9.3M was announced in Mar 2026.
Theolytics Founders and Leadership Team
Contact details for the Theolytics team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Theolytics Funding Compared to Other Biotechnology Startups
Theolytics' latest round of $9.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Theolytics in Biotechnology and Oxford
Companies Similar to Theolytics
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Theolytics Funding FAQs
What does Theolytics do?
Theolytics is a biotechnology company in the clinical stage that uses viruses to fight against diseases. Our innovative phenotypic screening Platform allows for the development of effective and targeted candidate treatments, suitable for intravenous delivery and tailored to specific patient groups. Along with progressing our own programs for treating both solid and liquid tumors, we are forming partnerships to further expand and speed up the development of our pipeline.
How much funding has Theolytics raised?
Theolytics has raised $67.6M across 4 rounds on record. The most recent is an undisclosed round of $9.3M announced in Mar 2026.
When did Theolytics last raise funding?
Theolytics' most recent funding round on record is an undisclosed round of $9.3M, announced in Mar 2026.
Who founded Theolytics?
FundedIQ lists David Apelian (Founder) at Theolytics.
Who is the CEO of Theolytics?
Charlotte Casebourne is listed as CEO at Theolytics.
Where is Theolytics headquartered?
Theolytics is based in Oxford, Oxfordshire, United Kingdom.
How many employees does Theolytics have?
Theolytics is in the 11-50 employee band.
How does Theolytics' funding compare to other Biotechnology startups?
Theolytics' latest round of $9.3M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Theolytics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Theolytics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.